Antal International reacquires Antal Russia
Antal International now has 884 staff members with a comprehensive 140+ offices located worldwide
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian pharma industry scores poorly on Digital Savvy Reps Survey
The study covered over 500 healthcare reps across US, China, India and rest of the world
Glenmark receives tentative ANDA approval for Saxagliptin
It is the generic version of Onglyza Tablets, 2.5 mg and 5 mg of AstraZeneca
IIL to expand its protozoan Vaccine portfolio
It aims to control haemoprotozoan diseases to prevent loss of productivity in cattle.
Sun Pharma receives US FDA approval for ezetimibe
The generic ezetimibe tablets are therapeutic equivalents of Merck’s Zetia tablets
OPPI hosted its sixth Healthcare Access Summit
The summit focussed on bringing policies into best practices in NCDs’ and was supported by MoH&FW, DoP, Ministry of Chemicals…
Ecron Acunova to offer end-to-end capabilities as ‘Navitas Life Sciences’
Navitas Life Sciences will consolidate capabilities of Ecron Acunova, Navitas and Intelent
Mylan and Biocon present clinical data on Insulin Glargine at ADA
Data shows comparable efficacy, safety and immunogenicity to Lantus in Type I and Type II Diabetes Patients
Ozone Pharma introduces DFO 4X Gel
The brand also launched a campaign in May, 2017, named, Dard Baanton Nahi, Mitao, addressing the consumers common pain points
Aptar Pharma extends its CR nasal pump manufacturing capabilities in North America
Aptar Pharma’s Child-Resistant Feature for nasal sprays combines Child-Resistance (CR) and Senior-Friendliness (SF) with its…